drugset / Trial / NCT04386811
Vitamin D as a Therapeutic Adjunct in the Stimulant Treatment of ADHD: a Proof-of-concept Tele-health Study of Stimulant-induced Improvement in Neurocognitive Functioning.
RandomizedCrossoverSingle-blindTreatment
Summary
The purpose of this study is to assess vitamin D as a therapeutic adjunct in the stimulant treatment of ADHD.
Timeline
- Start
- 2020-08-05
- Primary completion
- 2020-09-29
- Completion
- 2020-09-29
Outcome
Outcome not reported
Stopped (Business): “Following Yale University resuming in-person research activities, the investigators no longer had dedicated funding for the study and were unable to secure additional funding to meet the research goals.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Calcitriol | Small molecule | — | — |